This chapter outlines the important and common late-onset, long-term endocrine disorders that occur as a consequence of cancer therapy in survivors: bone metabolism disorders, metabolic (i.e., glucose and lipid) disorders, thyroid neoplasia and dysfunction, hypothalamic-pituitary dysfunction, adrenal dysfunction, and gonadal system disorders. Strategies for evaluating and managing these effects are included.
CITATION STYLE
Hu, M. I., Jimenez, C., Busaidy, N. L., & Habra, M. A. (2015). Endocrinologic issues. In Advances in Cancer Survivorship Management (pp. 343–360). Springer New York. https://doi.org/10.1007/978-1-4939-0986-5_21
Mendeley helps you to discover research relevant for your work.